These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3243571)

  • 1. Involvement of chromosomal breakpoints at 1p21, 1q23, 6q14, 9p23 and 14q24 in tumour cells of effusions of a patient with adenocarcinoma of suspected primary at large bowel.
    Murty VV; Mitra AB; Agarwal SK; Das DK
    Indian J Cancer; 1988 Dec; 25(4):230-4. PubMed ID: 3243571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Presumption of primary sites from cytological findings--with reference to adenocarcinoma cells in the effusions in body cavities].
    Takamura Y; Tajima M
    Rinsho Byori; 1990 Nov; Suppl 87():126-40. PubMed ID: 2287083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rearrangement of the chromosome 17 in colonic adenocarcinoma].
    Muleris M; Salmon R; Zafrani B; Girodet J; Dutrillaux B
    C R Acad Sci III; 1985; 300(8):315-8. PubMed ID: 3922580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
    Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
    Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopic studies of cells in pleural and peritoneal effusions.
    Murad TM
    Acta Cytol; 1973; 17(5):401-9. PubMed ID: 4517952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chromosome changes in ascitic effusions of neoplastic origin].
    Mariscotti C; Gallareto M; Zaccone G; Canobbio G; Salamano M
    Arch Sci Med (Torino); 1978; 135(3):383-96. PubMed ID: 708089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetics of neoplastic effusions].
    Casini C; Scorretti L; Torlonia G; Uccellatore F
    Minerva Ginecol; 1975 Jun; 27(6):472-82. PubMed ID: 1153125
    [No Abstract]   [Full Text] [Related]  

  • 9. The potential value of comparative genomic hybridization analysis in effusion-and fine needle aspiration cytology.
    Nagel H; Schulten HJ; Gunawan B; Brinck U; Füzesi L
    Mod Pathol; 2002 Aug; 15(8):818-25. PubMed ID: 12181266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytogenetics in the diagnosis of malignancy in effusions].
    Bello MJ; Rey JA; Ramos C; Santillán S; Ibáñez A
    Rev Clin Esp; 1983 May; 169(4):229-32. PubMed ID: 6622766
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chromosome composition of ascitic and pleural fluid cells in cancer].
    Genes IS
    Vopr Onkol; 1970; 16(9):39-45. PubMed ID: 5486440
    [No Abstract]   [Full Text] [Related]  

  • 12. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acrocentric marker chromosomes in malignant effusions and solid tumors.
    Benedict WF; Brown CD; Porter IH
    N Y State J Med; 1971 May; 71(9):952-5. PubMed ID: 5280177
    [No Abstract]   [Full Text] [Related]  

  • 14. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.
    van de Molengraft FJ; van 't Hof MA; Herman CJ; Vooijs PG
    Anal Quant Cytol; 1982 Sep; 4(3):217-20. PubMed ID: 7149486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cells affected by apoptosis in effusions of tumor origin in man].
    Gotzos V; Cappelli-Gotzos B; Conti G
    Ann Pathol; 1984; 4(3):217-21. PubMed ID: 6477687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases.
    Taetle R; Aickin M; Yang JM; Panda L; Emerson J; Roe D; Adair L; Thompson F; Liu Y; Wisner L; Davis JR; Trent J; Alberts DS
    Genes Chromosomes Cancer; 1999 Jul; 25(3):290-300. PubMed ID: 10379876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis.
    Simon R; Desper R; Papadimitriou CH; Peng A; Alberts DS; Taetle R; Trent JM; Schäffer AA
    Genes Chromosomes Cancer; 2000 May; 28(1):106-20. PubMed ID: 10738309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytologic findings in pleural and peritoneal effusions].
    Meschino S; Di Paolo N; Giovannelli G; Lunghetti R; Massari F
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(2):977-93. PubMed ID: 4904864
    [No Abstract]   [Full Text] [Related]  

  • 20. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.